The title compound (1, trivial name: 9 (or 3)-nitrocytisine) crystallizes with two independent molecules in the asymmetric unit. In its structure two rings form a bispidine framework that is fused to a 3-nitro-2-pyridone group. The half-normal probability plot reveals that the two molecules do not show any significant geometrical differences, except in conformations of the nitro-group, which is involved in intermolecular interactions. The crystal packing structure of the title compound is described in terms of three-dimensional supramolecular arrays built up from chains of N-H···O (nitro-group), hydrogen bonds and weak intermolecular C-H···O=C interactions, with graph-set descriptors C 2 (6) and C 2 (10) motifs, which together result in R 4 (26) rings motifs. These chains are additionally stabilized by intermolecular NO 2 ···p interactions.
INTRODUCTION
Cytisine, (1R,5S)-1,2,3,4,5,6-hexahydro-1,5-methanopyrido[1,2-a] [1, 5] diazocin-8-one, is a tricyclic quinolizidine alkaloid found in many plants belonging to the legume family (Fabaceae or Leguminosae). It is of medical interest as an aid to quit smoking, and has been used as such in Eastern Europe for more than forty years. 1, 2 It also served as a template for the design of the anti-smoking drug varenicline (Chantix®, Champix®). 3 Several pyridonering-substituted derivatives of cytisine have been examined in vitro as nicotinic acetylcholine receptor (nAChR) ligands, [4] [5] [6] [7] [8] [9] [10] [11] and a couple have been subjected to studies in rodents. [12] [13] [14] Most recently the title compound (1R,5S)-9-nitro-1,2,3,4,5,6-hexahydro-1,5-methanopyrido[1,2-a] [1, 5] diazocin-8-one (1, commonly referred to as 9-or 3-nitrocytisine) and its 11 (or 5)-nitro isomer, as well as their 9-bromo-11-nitro-and 11-bromo-9-nitro analogues, have been assayed in vitro vs. nicotinic receptors, and their affinities have been rationalized on the basis of molecular simulation (docking) studies. In particular, 9-(or 3)-nitrocytisine, as compared to varenicline, showed very similar nanomolar affinity for a4b2 nAChR and similar high selectivity over the a7 nAChR subtype, but with lower intrinsic efficacy, which might make it an interesting candidate for smoking cessation therapy.
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EXPERIMENTAL Synthesis
The nitration of cytisine was first reported in 1894, 16 and the isolation and characterization (but not the structure elucidation) of the title compound were described a few years later. 17 The latter procedure was followed in general terms in the present work. A cooled solution containing 1.00 g (5.26 mmol) of cytisine dissolved in 1.5 ml concentrated H 2 SO 4 was treated dropwise with 1.2 mL (19 mmol) of concentrated HNO 3 and left at room temperature for 5 h. The mixture was cooled again (0°C) and the reaction was stopped by adding NH 4 OH to adjust the pH to 9-10, followed by a standard extraction procedure with CH 2 Cl 2 . The organic phase was dried with anhydrous Na 2 SO 4 and solvents were removed under reduced pressure. The residue obtained was dissolved in 2.5 ml concentrated HCl, heated under reflux for 15 minutes and the solution neutralized by adding concentrated aqueous NH 3 . A mixture of 9-and 11-nitrocytisines was obtained after extracting with CH 2 Cl 2 . Finally, the mixture was fractionated using silica gel column chromatography (silica gel 60 Merck; mobile phase: conc. aq. NH 3 /MeOH/CH 2 Cl 2 , 1:10:89). The final isolated yields were 66% for 9-nitrocytisine (1) and 2% for 11-nitrocytisine. The 1 H NMR spectra of both products were in agreement with those already published. 18 The title compound was crystallized in acetone.
Structure determination
The collection of the intensity data was carried out with the SMART program. 19 Cell refinement and data reduction were done using SAINT. 19 The SHELXL package of crystallographic programs was used to solve and refine the structure. 20 A riding model was applied to H atoms, which were calculated geometrically (C-H: 0.93-0.98) and refined with U iso (H) values of 1.2U eq (C). H atoms of C1, C11 and N3 were found in difference Fourier maps and refined freely. The molecular graphics used to prepare material for publication were drawn using DIAMOND and PLATON. 21, 22 The crystal data are summarized in Table 1 .
RESULTS AND DISCUSSION
9-Nitrocytisine (1) crystallizes with two crystallographically independent but conformationally almost identical molecules in the asymmetric unit (Figure1). The molecule consists of three fused rings; a six-membered ring A in a near-chair conformation fused to a six-membered ring B in an envelope conformation, which in turn is condensed to the nitropyridone group ring C. Selected bond lengths and angles with their estimated standard deviations (esd`s) are given in Table 2 . Bond lengths, bond angles and torsion angles in the asymmetric unit of 9-nitrocytisine (1) closely approximate the mean geometry describing the molecular structure of structurally related compounds: (-)-cytisine, (-)-N-methylcytisine, N-cyanomethylcytisine and N-acetonylcytisine. Table 1 . Crystal data and details of the structure determination for compound (1). (1), showing the two independent molecules and atom numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and H atoms are shown as small spheres of arbitrary radii.
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A comparison of the bond distances and angles of the fitted residues, using a half-normal probability analysis, reveals that the two molecules do not show any significant geometrical differences (see Table 2 ). 26 The slope plot of the bond distances is 1.1874 and the intercept is 0.0377. The largest difference (0.0130 Å) is between the N1-C11A bond in the first molecule and N1'-C11A' in the second molecule (2.2981 D/s). The main difference between the two molecules lies in the conformations of the nitro-group, which is involved in intermolecular hydrogen bonding (see below), and the differences can thus be ascribed to crystal-packing effects. As a result, the dihedral O9A-N9-C9-C10 torsion angle of the nitro-group in the first molecule is 7.1(5)º (view table 2 . A similar geometry is observed in (-)-cytisine. 23 The C11a-C1-C2 bond angle in 1 is 109.6(3)º and N1 adopts a planar configuration [C11a-N1-C7 = 123.1(2)º]. The sum of the three angles about atom N 1 reflects sp 2 geometry (table 2) . The pyridone ring C (N1/ C11A/ C8-C11) in 1 is essentially planar (Figure 1 ). 
The two independent molecules in 1 form intermolecular interactions. N-H···O (nitro-group) hydrogen bonds and weak intermolecular C-H···O=C interactions (Table 1) link the molecules, with together are effective in the stabilization of the structure. The crystal packing structure contains chains that run along the crystallographic b-axis, generated by the classical N-H···O hydrogen bonds forming a graph-set descriptor C 2 (10) motif (Figure 2 ).
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The overall effect is that the N3-H3···O9B´ [-x+1,y-1/2,-z+1] and N3´-H3´···O9B [-x+1,y-1/2,-z+1] interactions form an infinite one-dimensional chain zigzagging parallel to the [010] plane (table 3 and figure 2 ). The intermolecular C11-H11···O8´ [x,y,z+1] and C1´-H1´···O8 [x,y,z] interactions form a graph-set descriptor C 2 (10) motif as viewed along the c-axis, with H-acceptor distances which are less than the sum of the van der Waals radii (table 3 and figure 2) . [30] [31] The combination of these two interactions (N-H···O and C-H···O=C) produces two types of R 4 (26) ring motifs ( Figure 3 ). The first motif is formed by of N3-H3···O9B hydrogen bonds and C11-H11···O8´ [x,y,z+1] interactions. The second motif is the formation of N3-H3···O9B and C1´-H1´···O8 [x,y,z] interactions. The supramolecular structure is additionally stabilized by intermolecular NO 2 ···p interactions, [32] [33] with connect the Cg centroids of the N1/C11A/C8-C11 rings with the O9B atoms of the nitro group (Figure 3 and table 3) . Table 3 . Hydrogen-bond and intermolecular contact interaction geometry (Å, º). 
